Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Abigail D Winder"'
Autor:
Kenji Unno, Masanori Ono, Abigail D Winder, Kruti P Maniar, Ajit S Paintal, Yanni Yu, Jian-Jun Wei, John R Lurain, J Julie Kim
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e116064 (2014)
ObjectiveMost endometrial cancers are detected early and have a good prognosis, while some endometrial cancers are highly invasive, metastasize early, and respond suboptimally to therapy. Currently, appropriate model systems to study the aggressive n
Externí odkaz:
https://doaj.org/article/013d57a3cfe64d4bb55de21de84649d5
Autor:
Lindsey A. McAlarnen, Kelly Ryan, William Adams, Adam Gliniewicz, Abigail D. Winder, Margaret R. Liotta, Ronald K. Potkul, William Small, Jr, Matthew M. Harkenrider
Publikováno v:
Gynecologic Oncology Reports, Vol 29, Iss , Pp 1-6 (2019)
Regional recurrence of endometrial cancer is a challenging yet potentially curable group of patients without defined standard of care. Our aim is to determine optimal methods of salvage therapy for regionally recurrent endometrial cancer.Twenty-two c
Externí odkaz:
https://doaj.org/article/494d6d6533bc44469d2bb733d5d5d6f8
Publikováno v:
Gynecologic Oncology Reports, Vol 21, Iss C, Pp 34-36 (2017)
Externí odkaz:
https://doaj.org/article/c0b8cc3dce604f4fafcff5a586f0b7d6
Autor:
Adriana Stoica, Matthew Eagan, Antai Wang, Jessica Duncan, Heather Summe, Mary C. Iann, Robert L. Russell, Michael Simoneaux, Fengming Hu, Kevin Lehnes, Natasha Kasid, Charles H. Evans, Elisha Morgan, Camille Alfonso, Raluca Tavaluc, Abigail D. Winder
Publikováno v:
Endocrinology. 148:1171-1180
To determine whether the epidermal growth factor receptor 2 (ErbB2) and Akt1 can alter the in vivo growth of MCF-7 cells, parental cells or cells stably transfected with constitutively active Akt1 (myr-Akt1) or dominant-negative Akt1 mutants (K179M-A
Autor:
Adriana Stoica, Abigail D Winder, Elisha Morgan, Ronald Reiter, Susette C. Mueller, Mary C. Iann, Thomas F. Franke, Maria Moroni, Mary Beth Martin, Anton Wellstein, Gerald E. Stoica
Publikováno v:
Oncogene. 22:7998-8011
Epidermal growth factor (EGF), insulin-like growth factor-I (IGF-I), and heregulin-beta1 (HRG-beta1), can modulate the expression and activity of the estrogen receptor-alpha (ER-alpha) via the phosphatidylinositol 3-kinase (PI 3-K)/Akt pathway in the